Daiichi Sankyo Co Ltd 2015 IR
The report highlights Daiichi Sankyo Group's transition to a business model focused on its innovative business, following the divestment of its former Indian subsidiary, Ranbaxy Laboratories. Key achievements in fiscal 2014 include the global launch of the oral anticoagulant edoxaban in Japan and the U.S., and the acquisition of Ambit Biosciences to strengthen its oncology pipeline. The company also restructured its domestic operations and established a new global management direction prioritizing investments in Japan, the U.S., and China. Additionally, the Group advanced its environmental management, reducing CO2 emissions and conducting Whole Effluent Toxicity tests to minimize ecological impacts.
Company: Daiichi Sankyo Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2015
Type: IR
Pages: 49
Back to company
Daiichi Sankyo Co Ltd
Value Report
The report highlights Daiichi Sankyo Group's transition to a business model focused on its innovative business, following the divestment of its former Indian subsidiary, Ranbaxy Laboratories. Key achievements in fiscal 2014 include the global launch of the oral anticoagulant edoxaban in Japan and the U.S., and the acquisition of Ambit Biosciences to strengthen its oncology pipeline. The company also restructured its domestic operations and established a new global management direction prioritizing investments in Japan, the U.S., and China. Additionally, the Group advanced its environmental management, reducing CO2 emissions and conducting Whole Effluent Toxicity tests to minimize ecological impacts.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Apr 1, 2014 - Mar 31, 2015
Fiscal Year
2014
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Employees